Label Value
DOI 10.1186/s12885-017-3527-7
TITLE Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
TYPE article
PUBLICATION DATE
Service Status Date Last Checked
Scopus Yes 2017-12-17T15:17:27.210929+00:00
Web of Science Yes 2018-04-08T04:06:09.799843
Compendex No 2019-12-18T12:52:18.517477